Abstract

Leukocytes respond to lipopolysaccharide (LPS) at nanogram per milliliter concentrations with secretion of cytokines such as tumor necrosis factor-α (TNF-α). Excess secretion of TNF-α causes endotoxic shock, an often fatal complication of infection. LPS in the bloodstream rapidly binds to the serum protein, lipopolysaccharide binding protein (LBP), and cellular responses to physiological levels of LPS are dependent on LBP. CD14, a differentiation antigen of monocytes, was found to bind complexes of LPS and LBP, and blockade of CD14 with monoclonal antibodies prevented synthesis of TNF-α by whole blood incubated with LPS. Thus, LPS may induce responses by interacting with a soluble binding protein in serum that then binds the cell surface protein CD14.

Keywords

Lipopolysaccharide binding proteinCD14LipopolysaccharideTumor necrosis factor alphaSecretionReceptorAntibodyMonoclonal antibodyChemistryBinding proteinMolecular biologyBiologyImmunologyEndocrinologyBiochemistry

Affiliated Institutions

Related Publications

Publication Info

Year
1990
Type
article
Volume
249
Issue
4975
Pages
1431-1433
Citations
3992
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

3992
OpenAlex

Cite This

Samuel D. Wright, Robert Ramos, Peter S. Tobias et al. (1990). CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein. Science , 249 (4975) , 1431-1433. https://doi.org/10.1126/science.1698311

Identifiers

DOI
10.1126/science.1698311